These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34579243)

  • 21. The presence of cross-reactive antibodies to rabbit haemorrhagic disease virus in Australian wild rabbits prior to the escape of virus from quarantine.
    Nagesha HS; McColl KA; Collins BJ; Morrissy CJ; Wang LF; Westbury HA
    Arch Virol; 2000; 145(4):749-57. PubMed ID: 10893153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serological characterisation of
    Krejmer-Rąbalska M; Peplińska M; Szewczyk B; Fitzner A
    J Vet Res; 2024 Mar; 68(1):9-17. PubMed ID: 38525228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chimeric RHDV Virus-Like Particles Displaying Foot-and-Mouth Disease Virus Epitopes Elicit Neutralizing Antibodies and Confer Partial Protection in Pigs.
    Rangel G; Bárcena J; Moreno N; Mata CP; Castón JR; Alejo A; Blanco E
    Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34066934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral immunization of rabbits with VP60 particles confers protection against rabbit hemorrhagic disease.
    Plana-Duran J; Bastons M; Rodriguez MJ; Climent I; Cortés E; Vela C; Casal I
    Arch Virol; 1996; 141(8):1423-36. PubMed ID: 8856024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant
    Wang L; Xia T; Guo T; Ru Y; Jiang Y; Cui W; Zhou H; Qiao X; Tang L; Xu Y; Li Y
    Vaccines (Basel); 2019 Nov; 7(4):. PubMed ID: 31684059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single dose adenovirus vectored vaccine induces a potent and long-lasting immune response against rabbit hemorrhagic disease virus after parenteral or mucosal administration.
    Fernández E; Toledo JR; Chiong M; Parra F; Rodríguez E; Montero C; Méndez L; Capucci L; Farnós O
    Vet Immunol Immunopathol; 2011 Aug; 142(3-4):179-88. PubMed ID: 21621855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved Production Efficiency of Virus-Like Particles by the Baculovirus Expression Vector System.
    López-Vidal J; Gómez-Sebastián S; Bárcena J; Nuñez Mdel C; Martínez-Alonso D; Dudognon B; Guijarro E; Escribano JM
    PLoS One; 2015; 10(10):e0140039. PubMed ID: 26458221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical and structural characterization of RHDV capsid protein variants produced in Pichia pastoris: advantages for immunization strategies and vaccine implementation.
    Farnós O; Fernández E; Chiong M; Parra F; Joglar M; Méndez L; Rodríguez E; Moya G; Rodríguez D; Lleonart R; González EM; Alonso A; Alfonso P; Suárez M; Rodríguez MP; Toledo JR
    Antiviral Res; 2009 Jan; 81(1):25-36. PubMed ID: 18824033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural, antigenic and immunogenic relationships between European brown hare syndrome virus and rabbit haemorrhagic disease virus.
    Laurent S; Vautherot JF; Le Gall G; Madelaine MF; Rasschaert D
    J Gen Virol; 1997 Nov; 78 ( Pt 11)():2803-11. PubMed ID: 9367366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of novel rabbit hemorrhagic disease virus B-cell epitopes and their interaction with host histo-blood group antigens.
    Song Y; Wang F; Fan Z; Hu B; Liu X; Wei H; Xue J; Xu W; Qiu R
    J Gen Virol; 2016 Feb; 97(2):356-365. PubMed ID: 26612210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Folding of the rabbit hemorrhagic disease virus capsid protein and delineation of N-terminal domains dispensable for assembly.
    Laurent S; Kut E; Remy-Delaunay S; Rasschaert D
    Arch Virol; 2002 Aug; 147(8):1559-71. PubMed ID: 12181675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virus-like particles of calicivirus as epitope carriers.
    Nagesha HS; Wang LF; Hyatt AD
    Arch Virol; 1999; 144(12):2429-39. PubMed ID: 10664395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening optimal DC-targeting peptide to enhance the immune efficacy of recombinant
    Xia T; Lu X; Kong D; Guo T; Gao Y; Xin L; Jiang Y; Wang X; Shan Z; Li J; Zhou H; Cui W; Qiao X; Tang L; Li Y; Wang L
    Virulence; 2024 Dec; 15(1):2368080. PubMed ID: 38899573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenic properties of rabbit haemorrhagic disease virus structural protein VP60 expressed by a recombinant baculovirus: an efficient vaccine.
    Marín MS; Martín Alonso JM; Pérez Ordoyo García LI; Boga JA; Argüello-Villares JL; Casais R; Venugopal K; Jiang W; Gould EA; Parra F
    Virus Res; 1995 Dec; 39(2-3):119-28. PubMed ID: 8837879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of two novel rabbit hemorrhagic disease virus (RHDV) B cell epitopes and evaluation of its immunoprotection against RHDV.
    DeSheng K; HuaiRan L; JiaSen L; Zuo Y; Qian J; DongChun G; XiaoLiang H; FengJie W; QianQian H; LianDong Q
    Appl Microbiol Biotechnol; 2015 Jul; 99(14):5951-66. PubMed ID: 25895085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multi-target chimaeric VLP as a therapeutic vaccine in a model of colorectal cancer.
    Donaldson B; Al-Barwani F; Pelham SJ; Young K; Ward VK; Young SL
    J Immunother Cancer; 2017 Aug; 5(1):69. PubMed ID: 28806910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a low-cost, insect larvae-derived recombinant subunit vaccine against RHDV.
    Pérez-Filgueira DM; Resino-Talaván P; Cubillos C; Angulo I; Barderas MG; Barcena J; Escribano JM
    Virology; 2007 Aug; 364(2):422-30. PubMed ID: 17434554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chimeric calicivirus-like particles elicit protective anti-viral cytotoxic responses without adjuvant.
    Crisci E; Almanza H; Mena I; Córdoba L; Gómez-Casado E; Castón JR; Fraile L; Bárcena J; Montoya M
    Virology; 2009 May; 387(2):303-12. PubMed ID: 19327809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant effects of interleukin-2 co-expression with VP60 in an oral vaccine delivered by attenuated Salmonella typhimurium against rabbit hemorrhagic disease.
    Deng Z; Geng Y; Wang K; Yu Z; Yang PO; Yang Z; He C; Huang C; Yin L; He M; Tang L; Lai W
    Vet Microbiol; 2019 Mar; 230():49-55. PubMed ID: 30827404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
    Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
    J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.